Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 1
1(33.3%)
3Total
N/A(2)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05730595Not ApplicableNot Yet Recruiting

Fluorescence Laparoscopic Navigation for Rectal Cancer and Sigmoid Colon Cancer

Role: collaborator

NCT05140837Unknown

Early Diagnosis and Timely Treatment of Cirrhotic Patients With Minimal Hepatic Encephalopathy (CHESS-NCRCID 2106)

Role: collaborator

NCT01935635Phase 1Completed

A Clinical Trial on HB-Vac Activated-DCs Combined With Peg-IFN or NAs in CHB

Role: collaborator

NCT03010748Unknown

Multi-center Clinical Trial on Corneal Morphology Analysis in Chinese Population

Role: collaborator

NCT02231606Not ApplicableCompleted

Potentiating Rural Investment in Children's Eyecare (PRICE)

Role: collaborator

All 5 trials loaded